文献速递肝病

慢加急性肝衰竭的重症监护病房病程与结局与其他重症监护人群相当

The intensive care unit course and outcome in acute-on-chronic liver failure are comparable to other populations.
PubMed 文献 · J Hepatol · 2018-05-04

本研究基于EPaNIC随机对照试验数据库,比较133例肝硬化患者中71例符合ACLF标准者与匹配的71例脓毒症及71例内科ICU患者的临床病程与宿主反应。结果显示ACLF患者的ICU住院时间、新发感染、器官衰竭、脓毒症休克及ICU、住院和90天死亡率与匹配对照组相似,但C反应蛋白和血小板水平较低,TNF-α水平较高。

要点

  • ACLF患者与病情严重度匹配的其他ICU患者相比,ICU住院时间、新发感染、器官衰竭及死亡率相似。
  • ACLF患者第一周C反应蛋白和血小板水平较低。
  • ACLF患者第1天TNF-α水平高于脓毒症ICU患者,其他细胞因子相似。

核心结论

  • 入住ICU的ACLF患者,在基线病情严重度特征匹配的情况下,临床过程和ICU结局与无慢性肝病的ICU患者相当。
  • 作者认为ICU入住标准不应因ACLF人群而不同。

研究设计与样本

  • 基于大型前瞻性EPaNIC随机对照试验数据库(n=4,640)的队列研究,共纳入213例患者。
  • 识别出133例肝硬化患者,其中71例符合慢性肝衰竭联盟ACLF标准。
  • 将71例ACLF患者按疾病类型、严重度和人口学特征与71例脓毒症ICU患者及71例无慢性肝病的内科ICU患者进行匹配。
  • 在100例子集中量化了第1天血清细胞因子。

主要发现

  • ACLF与脓毒症或内科ICU患者相比,ICU住院时间、新发感染、器官衰竭和脓毒症休克相似。
  • ACLF组与匹配组的ICU死亡率、住院死亡率和90天死亡率相似。
  • ACLF患者第一周内C反应蛋白和血小板水平较低。
  • 第1天IL-10、IL-1β、IL-6和IL-8在ACLF与脓毒症ICU患者中升高程度相似。
  • ACLF患者TNF-α水平较高。

临床怎么用

  • 作者认为ACLF患者的ICU入住标准不应与其他ICU人群不同。
  • 作者指出ACLF患者应获得与其他ICU人群相同的ICU照护。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Acute-on-chronic liver failure (ACLF) is characterized by acute decompensation of cirrhosis, development of organ failure and high short-term mortality. Whether the outcome in patients admitted to the intensive care unit (ICU) with ACLF differs from other ICU populations is unknown. We compared the clinical course and host response in ICU patients with or without ACLF, matched for baseline severity of illness scores and characteristics. METHODS: From the large prospective EPaNIC randomized control trial database (n = 4,640), 133 patients were identified with cirrhosis of whom 71 fulfilled the Chronic Liver Failure Consortium criteria for ACLF. These patients were matched for type and severity of illness and demographics to 71 septic and 71 medical ICU patients from the same database without chronic liver disease. Clinical, biochemical and outcome parameters were compared in this cohort study of 213 patients. In a subset of 100 patients, day 1 serum cytokines were quantified. RESULTS: The outcome of ACLF, when compared to septic or medical ICU patients, matched for baseline parameters of illness severity, was similar regarding length of ICU stay, development of new infections, organ failure and septic shock. ICU, hospital and 90-day mortality were similar between the groups. C-reactive protein and platelet levels were lower in patients with ACLF throughout the first week. Cytokines, including IL-10, IL-1β, IL-6, and IL-8, were similarly elevated in ACLF and septic ICU patients on day 1. However, TNF-α levels were higher in patients with ACLF. CONCLUSION: Patients with ACLF admitted to the ICU showed comparable clinical and ICU outcomes as ICU patients without chronic liver disease, but with similar baseline severity of illness characteristics. This suggests that ICU admission criteria should not be different in ACLF populations. LAY SUMMARY: Liver function may abruptly deteriorate in patients with chronic liver disease with cirrhosis, often resulting in these patients being admitted to an intensive care unit (ICU) with organ failure. Previous studies have indicated that this sudden deterioration, called acute-on-chronic liver failure is associated with very high mortality rates, which often resulted in deferred ICU care because of a perception of futility. Our study now shows that the ICU course and outcome are not different when patients with acute-on-chronic liver failure are compared to other ICU patients matched for severity of illness. This demonstrates that patients with acute-on-chronic liver failure deserve the same ICU care given to other ICU populations.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Meersseman P, Langouche L, du Plessis J, et al. The intensive care unit course and outcome in acute-on-chronic liver failure are comparable to other populations. J Hepatol. 2018. PMID: 29730473. doi:10.1016/j.jhep.2018.04.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。